WallStreetZenWallStreetZen

NASDAQ: XRTX
Xortx Therapeutics Inc Earnings & Revenue

XRTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$5.8M
Current Profit Margin
0%

XRTX Return on Equity

Current Company
-105.3%
Current Industry
15.4%
Current Market
-8.4%
XRTX's Return on Equity (-97.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XRTX announces earnings.

XRTX Return on Assets

Current Company
-85.3%
Current Industry
2.2%
XRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XRTX Return on Capital Employed

Current Company
-128.95%
Current Industry
17.7%

XRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XRTX$0.00-$5.58M-$5.63MN/AN/A
PTIX$0.00-$4.86M-$5.00MN/AN/A
IBIO$50.00k-$25.95M-$27.28M-43.46%N/A
ATXI$0.00-$10.38M-$10.38MN/AN/A
VCNX$570.00k-$20.13M-$20.25M-4.67%N/A

XRTX earnings dates

Next earnings date
May 15, 2024

Xortx Therapeutics Earnings & Revenue FAQ

What were XRTX's earnings last quarter?

On Invalid Date, Xortx Therapeutics (NASDAQ: XRTX) reported Q3 2023 earnings per share (EPS) of -$0.50, up 21.14% year over year. Total Xortx Therapeutics earnings for the quarter were -$987.68 thousand. In the same quarter last year, Xortx Therapeutics's earnings per share (EPS) was -$0.63.

If you're new to stock investing, here's how to buy Xortx Therapeutics stock.

What was XRTX's earnings growth in the past year?

As of Q2 2024, Xortx Therapeutics's earnings has grown year over year. Xortx Therapeutics's earnings in the past year totalled -$5.63 million.

What is XRTX's earnings date?

Xortx Therapeutics's earnings date is Invalid Date. Add XRTX to your watchlist to be reminded of XRTX's next earnings announcement.

What was XRTX's revenue last quarter?

On Invalid Date, Xortx Therapeutics (NASDAQ: XRTX) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Xortx Therapeutics's revenue was $0.00.

What was XRTX's revenue growth in the past year?

As of Q2 2024, Xortx Therapeutics's revenue has grown null year over year. Xortx Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.